Boxer Capital’s Million Corvus Bet Signals Confidence
Boxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...
Investors needing highly customized portfolios or personal financial planning may prefer traditional advisory services over automated solutions.
24,498 articlesBoxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...
Investors are buzzing as micron just delivered massive momentum for MU. This article breaks down what happened, why i...
Coinbase just delivered fantastic news for investors by expanding beyond crypto into stocks and ETFs. This article br...
Curious about a strategy that blends stock ownership with option income? This deep-dive on the JPMorgan Equity Premiu...
In the first half of 2026, Sandisk towered over the S&P 500. This article explains the drivers behind that outperform...
Institutional buyers are quietly backing a select set of artificial intelligence (ai) stock for 2026. This deep dive ...
Investors are eyeing Cerebras Systems' chips faster claims against Nvidia's Blackwell models. This deep dive explains...
SpaceX surged on its IPO buzz, then cooled as investors weighed the risk and reward. This guide breaks down what a 30...
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
Navitas Semiconductor has ridden a wave of AI infrastructure enthusiasm as data-center spending strengthens. This art...
Palantir has cooled off after a blazing run, but analysts say there's still meaningful upside. This guide breaks down...
Two popular U.S. dividend ETFs take different paths to income. This guide breaks down how SCHD and FDVV approach divi...